Polyglutamine Disease Modeling: Epitope Based Screen for Homologous Recombination using CRISPR/Cas9 System

Area of Science:

• Stem cell research
• Gene editing
• Neurodegenerative diseases

Background:

• Huntington's disease (HD) is a genetic neurodegenerative disorder.
• Previous studies corrected HD using homologous recombination (HR).

Purpose of the Study:

• To enhance the efficiency of generating isogenic Huntington's disease models.
• To utilize CRISPR-Cas9 genome editing for improved recombination efficiency.

Main Methods:

• Employed CRISPR-based genome editing in human cells.
• Developed a rapid antibody-based screening method to assess recombination efficiency.
• Generated allelic isogenic Huntington's disease models.

Main Results:

• CRISPR-Cas9 significantly improved recombination efficiency compared to traditional HR.
• The antibody-based screen effectively measured genome editing efficiency.
• Established a robust method for modeling polyglutamine diseases.

Conclusions:

• CRISPR-Cas9 offers a more efficient approach for modeling Huntington's disease.
• The developed screening method is valuable for assessing genome editing efficiency in polyglutamine disease research.
• This work facilitates the study of factors influencing CRISPR/Cas9 homology-directed repair.